From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

EXTON, PA — Frontage Laboratories, Inc. hosted a grand opening event to unveil its newest Contract Research, Development, and ...

Around 20% of these centres have expanded their footprint across three or more cities, signalling a trend towards multi-city ...

In 2018, the FDA began an investigation into nitrosamine impurities in drugs that led to high-profile recalls for heartburn ...

Pharmaceutical Promotion and Development Scheme (PPDS ... 17 Apr 25 The cumulative exports (merchandise & services) during FY25 (April-March) is estimated to grow by 5.50% at US$ 820.93 billion, as ...

A HEALTH and Pharmaceutical Investment Mission is set to be hosted from today (Monday, June 2, 2025), led by the European Union (EU) Delegation in ...

Robert F. Kennedy Jr. continues his anti-vax crusade by cancelling million-dollar bird flu vaccine deal with Moderna.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

North America Leads the Market: In 2023, North America accounted for over 50% of global revenue in the pharmaceutical dissolution testing services market. This dominance is driven by the strong ...